Publications

Found 86 results
Filters: Keyword is Humans  [Clear All Filters]
2013
Koff WC, Burton DR, Johnson PR, Walker BD, King CR, Nabel GJ, Ahmed R, Bhan MK, Plotkin SA.  2013.  Accelerating next-generation vaccine development for global disease prevention.. Science. 340(6136):1232910.
Kulp DW, Schief WR.  2013.  Advances in structure-based vaccine design.. Curr Opin Virol. 3(3):322-31.
Crispin M, Bowden TA.  2013.  Antibodies expose multiple weaknesses in the glycan shield of HIV.. Nat Struct Mol Biol. 20(7):771-2.
Gavrilyuk J, Ban H, Uehara H, Sirk SJ, Saye-Francisco K, Cuevas A, Zablowsky E, Oza A, Seaman MS, Burton DR et al..  2013.  Antibody conjugation approach enhances breadth and potency of neutralization of anti-HIV-1 antibodies and CD4-IgG.. J Virol. 87(9):4985-93.
Isik G, P Y Chung N, van Montfort T, Menis S, Matthews K, Schief WR, Moore JP, Sanders RW.  2013.  An HIV-1 envelope glycoprotein trimer with an embedded IL-21 domain activates human B cells.. PLoS One. 8(6):e67309.
Porichis F, Hart MG, Zupkosky J, Barblu L, Kaufmann DE.  2013.  In vitro assay to evaluate the impact of immunoregulatory pathways on HIV-specific CD4 T cell effector function.. J Vis Exp. (80):e50821.
Klasse P J, Depetris RS, Pejchal R, Julien J-P, Khayat R, Lee J H, Marozsan AJ, Cupo A, Cocco N, Korzun J et al..  2013.  Influences on trimerization and aggregation of soluble, cleaved HIV-1 SOSIP envelope glycoprotein.. J Virol. 87(17):9873-85.
Zhou T, Zhu J, Wu X, Moquin S, Zhang B, Acharya P, Georgiev IS, Altae-Tran HR, Chuang G-Y, M Joyce G et al..  2013.  Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies.. Immunity. 39(2):245-58.
Sok D, Moldt B, Burton DR.  2013.  SnapShot: broadly neutralizing antibodies.. Cell. 155(3):728-728.e1.
Pancera M, Shahzad-ul-Hussan S, Doria-Rose NA, McLellan JS, Bailer RT, Dai K, Loesgen S, Louder MK, Staupe RP, Yang Y et al..  2013.  Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16.. Nat Struct Mol Biol. 20(7):804-13.
Ferguson AL, Mann JK, Omarjee S, Ndung'u T, Walker BD, Chakraborty AK.  2013.  Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design.. Immunity. 38(3):606-17.
Ahmed R, Burton DR.  2013.  Viral vaccines: past successes and future challenges.. Curr Opin Virol. 3(3):307-8.

Pages